BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2015
View Archived Issues
AQP-4 inhibition improves survival of cardiac allografts in mice
Read More
Levetiracetam shows potential for the treatment of PVL
Read More
ISTH-0036 shows potential for the treatment of ophthalmic diseases
Read More
Daiichi Sankyo presents interaction study results for mirogabalin besylate
Read More
biOasis and partners awarded research grant focused on blood-brain barrier
Read More
Juno and Editas collaborate on next-generation CAR T and TCR therapies for cancer
Read More
Bayer partners with AACR to fund cancer research fellowships
Read More
Empagliflozin/metformin pill approved in E.U. for type 2 diabetes
Read More
Prevention of liver fibrosis using hydrodynamic gene delivery of MMP13
Read More
Pfizer launches grant program to study palbociclib in breast cancer
Read More
Seres Therapeutics doses first patient in C. difficile recurrent infection trial of SER-109
Read More
Celldex starts phase I/II trial of varlilumab and sunitinib in RCC
Read More
XBiotech cleared to start trial of antibody therapy for S.aureus infection
Read More
The Scripps Research Institute receives NIH grant to study novel obesity pathway
Read More
Merck & Co. files NDA for grazoprevir/elbasvir for HCV infection
Read More
IRM reports development of farnesoid X receptor agonists
Read More
Purdue Pharma discloses Nav1.7 sodium channel blockers
Read More
University of Montpellier and INSERM jointly patent new HER3 antibodies
Read More
Chymase inhibitors prepared and tested at Bayer
Read More
Merck & Co. synthesizes antidiabetic FFAR1 agonists
Read More
Pacira to conduct additional phase III trials to support sNDA for Exparel
Read More
Galenica to commercialize Roche's Mircera in U.S.
Read More
European Commission approves intermittent use of Esmya for long-term management of uterine fibroids
Read More
EMA validates MAA for emtricitabine/tenofovir alafenamide fumarate for HIV
Read More
Preliminary phase I data on PDS-0101 in patients with pre-cervical cancer
Read More